Find a Trial
Trial Results
4 protocol(s) meet the specified criteria
CTO-ALLOVIR-P-105-202OPEN TO ACCRUAL
Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant
CTO-SNDX-6352-0504OPEN TO ACCRUAL
AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic Therapy
IUSCC-0628OPEN TO ACCRUAL
Long-Term Adverse Health Outcomes in Survivors of Germ Cell Tumors Treated with High Dose Chemotherapy
IUSCC-0661OPEN TO ACCRUAL
The Indiana Myeloma Registry